Clinical Outcomes Associated with GLP-1 Receptor Agonist Exposure in Non-Diabetic Patients with Chronic Pancreatitis: A Retrospective Cohort Study. [PDF]
J Pers MedDhali A +4 more
europepmc +1 more source
Early Weight Regain After GLP-1 Receptor Agonist Discontinuation: Mechanisms and Implications for Treatment De-Escalation Strategies. [PDF]
Diabetes Obes MetabDamhof MA, van Bruggen FH, van Roon EN.
europepmc +1 more source
GLP-1 Receptor Agonist and Bariatric Surgery Utilization Among Adolescents and Young Adults.
JAMA PediatrMessiah SE +10 more
europepmc +1 more source
GLP-1 Receptor Agonist Use Is Associated With Lower Risk of Intracranial Aneurysm Rupture and Rupture Severity. [PDF]
StrokeChen H +14 more
europepmc +1 more source
Body Composition Changes During GLP-1 Receptor Agonist Therapy in Pediatric Obesity: A Pilot Study. [PDF]
MetabolitesPascu BM +4 more
europepmc +1 more source
Risk of Psychiatric Worsening With GLP-1 Receptor Agonist Use in Patients With Type 2 Diabetes and Treated Depression. [PDF]
Diabetes Obes MetabChang Y, Hsieh MH, Ju PC, Chang CC.
europepmc +1 more source
PT320, a GLP-1 receptor agonist, mitigates nucleus accumbens-associated depression- and anxiety-like behaviors in MitoPark mice of Parkinson's disease. [PDF]
J Parkinsons DisTseng KY +9 more
europepmc +1 more source
Perioperative GLP-1 Receptor Agonist Use and 30-Day Outcomes After Breast Cancer Surgery: A Retrospective Cohort Study. [PDF]
World J SurgAlsaleh N +4 more
europepmc +1 more source
Oral nonpeptide GLP-1 receptor agonist VCT220 for obesity treatment: a randomized, double-blind, phase II trial. [PDF]
Signal Transduct Target TherJi L +5 more
europepmc +1 more source